Skip to main content
. 2018 Jun 7;8(13):3597–3610. doi: 10.7150/thno.25608

Figure 7.

Figure 7

Therapeutic effects of r9-CN against primary tumor progression and lymphatic metastasis of breast cancer. (A) Tumor growth profiles of primary tumor from each group. (B) Inhibition of primary tumor growth by various formulations; *p < 0.05. (C) Body weight changes in mice from each group. (D) Typical images of metastatic lymph nodes from different treatments. (E) Inhibition of the metastatic lymph nodes by various formulations; *p < 0.05.